Heart Disease News and Research

Latest Heart Disease News and Research

Nine state, local organizations to receive NHLBI grant for COPD education initiatives

Nine state and local organizations will receive a total of $383,000 for chronic obstructive pulmonary disease education initiatives, the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, announced today.

1 Apr 2011

UTHealth initiates enrollment in study on promising surgical procedure for management of type 2 diabetes

Physicians at The University of Texas Health Science Center at Houston (UTHealth) have begun enrollment for a pilot study on a promising surgical approach for the management of Type 2 diabetes.

1 Apr 2011

Blue Cross and Blue Shield of Minnesota reports $9 billion revenue for 2010

Blue Cross and Blue Shield of Minnesota and its family of companies (Blue Cross) today announced audited financial results for 2010. The nonprofit health company reported full-year 2010 revenues of $9 billion and an operating margin of 1.4%, which resulted in a net operating income of $127 million. This marks the second consecutive year of positive operating results, following three consecutive years of operating losses from 2006 to 2008.

1 Apr 2011

CorMedix reports encouraging interim results from CRMD001 phase II study in Contrast Induced Acute Kidney Injury

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, today announced its interim analysis and clinical update for CRMD001.

1 Apr 2011

Sleep apnea along with excessive daytime sleepiness elevates risk of death in older adults

A study in the April 1 issue of the journal SLEEP suggests that the risk of death is more than two times higher in older adults who have sleep apnea and report struggling with excessive daytime sleepiness.

1 Apr 2011

New data confirms antiviral activity of fluvastatin in patients with HCV

New data presented today at the International Liver CongressTM confirm the antiviral activity of fluvastatin -- commonly used as a cholesterol-lowering treatment -- in patients with chronic hepatitis C.

1 Apr 2011

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

Merck, known as MSD outside of the United States and Canada, announced results from several new data analyses from the pivotal Phase III studies evaluating the addition of its investigational oral protease inhibitor VICTRELIS to peginterferon alfa-2b and ribavirin in adult patients with chronic hepatitis C virus genotype 1 infection.

1 Apr 2011

New research sheds light on Sudden Infant Death Syndrome

New research published today in The Journal of Physiology sheds light on areas of the brain thought to be the root cause of Sudden Infant Death Syndrome - the poorly understood condition also known as 'cot death'.

1 Apr 2011

Mitochondrial defect inherited from mother is linked to high blood pressure in one Chinese family

A specific genetic defect in one Chinese family shows that high blood pressure was inherited from the female parent, researchers report in Circulation Research: Journal of the American Heart Association.

1 Apr 2011

Catheter-related bloodstream infections in children

Hospitals can reduce the risk of life-threatening bloodstream infections in children with peripherally inserted central venous catheters by assessing daily the patient’s progress and removing the device as early as possible, according to a new Johns Hopkins Children’s Center study published online March 31 in the journal Clinical Infectious Diseases.

31 Mar 2011

Asuragen launches new miRNA Biofluids service offering

Asuragen, Inc. announced today the launch of its new miRNA Biofluids service offering designed to interrogate miRNAs from serum, plasma, cerebral spinal fluid, and urine. Supported by a growing body of literature, the utility of miRNA biomarkers in biofluids has been demonstrated for numerous disease areas including Cancer, Neurology, Autoimmune, and Cardiovascular diseases.

31 Mar 2011

FDA grants Nile Fast Track designation for cenderitide post-acute development program

Nile Therapeutics, Inc., a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Nile's post-acute development program for cenderitide, which has the goal of reducing cardiovascular mortality and cardiovascular re-hospitalization in the post-acute period in patients with acute decompensated heart failure.

31 Mar 2011

Micro-RNAs appear to play a key role in new mechanism underlying obesity

Max Planck researchers have discovered a new mechanism that leads to the development of type 2 diabetes in obesity. Body weight influences the risk of developing diabetes: between 80 and 90 percent of patients with type 2 diabetes are overweight or obese.

31 Mar 2011

Study: People who have survived diabetes for many decades exhibit few complications

Over time, diabetes can wreak havoc on the body's eyes, cardiovascular system, kidneys and nerves. A major study by Joslin Diabetes Center researchers, however, has found that some people who have survived diabetes for many decades exhibit remarkably few complications—a discovery that points toward the presence of protective factors that guard against the disease's effects.

31 Mar 2011

Important updates on spondyloarthritis highlighted at 2010 SPARTAN meeting

Spondyloarthritis is a group of inflammatory conditions causing spine and joint pain and deformity, mostly in young men. Important updates on the epidemiology, diagnosis, and treatment of SpA are presented in the April issue of The American Journal of the Medical Sciences, official journal of the Southern Society for Clinical Investigation.

31 Mar 2011

No amount of added sugar is right

According to a recently released study that traced the eating habits of Minnesota residents for 27 years, the body weight of Americans is rising along with their increased intake of sugars added to processed and home-cooked foods.

31 Mar 2011

Positive top-line data from Inhibitex INX-189 Phase 1b trial against HCV

Inhibitex, Inc. today reported positive top-line safety and antiviral data from its multiple ascending dose Phase 1b clinical trial of INX-189, an oral nucleotide polymerase inhibitor being developed to treat chronic infections caused by hepatitis C virus.

31 Mar 2011

McKesson releases Horizon Cardiology 12.2 cardiovascular information system

With its new 12.2 software release, McKesson's Horizon Cardiology™ is the industry's only cardiovascular information system (CVIS) system that offers a single database, including hemodynamics, and presents the entire patient history from fetal to adulthood.

31 Mar 2011

Study finds frequent anaemia in patients with chronic respiratory failure

A study of nearly 600 patients with severe non-inflammatory respiratory disease has found that a significant percentage also suffered from anaemia, according to the April issue of IJCP, the International Journal of Clinical Practice.

31 Mar 2011

Texas Children's Hospital and Baylor College of Medicine create Texas Children's Center for Global Health

Texas Children's Hospital and Baylor College of Medicine (BCM) today announced the creation of the Texas Children's Center for Global Health and the appointment of renowned physician-scientist Dr. Russell E. Ware as director.

31 Mar 2011

Heart Disease News and Research

Latest Heart Disease News and Research

Nine state, local organizations to receive NHLBI grant for COPD education initiatives

UTHealth initiates enrollment in study on promising surgical procedure for management of type 2 diabetes

Blue Cross and Blue Shield of Minnesota reports $9 billion revenue for 2010

CorMedix reports encouraging interim results from CRMD001 phase II study in Contrast Induced Acute Kidney Injury

Sleep apnea along with excessive daytime sleepiness elevates risk of death in older adults

New data confirms antiviral activity of fluvastatin in patients with HCV

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

New research sheds light on Sudden Infant Death Syndrome

Mitochondrial defect inherited from mother is linked to high blood pressure in one Chinese family

Catheter-related bloodstream infections in children

Asuragen launches new miRNA Biofluids service offering

FDA grants Nile Fast Track designation for cenderitide post-acute development program

Micro-RNAs appear to play a key role in new mechanism underlying obesity

Study: People who have survived diabetes for many decades exhibit few complications

Important updates on spondyloarthritis highlighted at 2010 SPARTAN meeting

No amount of added sugar is right

Positive top-line data from Inhibitex INX-189 Phase 1b trial against HCV

McKesson releases Horizon Cardiology 12.2 cardiovascular information system

Study finds frequent anaemia in patients with chronic respiratory failure

Texas Children's Hospital and Baylor College of Medicine create Texas Children's Center for Global Health

Innovation in neuroscience drug discovery - eBook eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Heart Disease News and Research

Latest Heart Disease News and Research

Innovation in neuroscience drug discovery - eBook eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in